The words “you have cancer” strike fear into the heart of people around the world. Recent scientific and medical advances in cancer care have dramatically improved survival rates and quality of life for patients. However, there is still much work to do.

Amgen advances all angles of care by delivering innovative treatments and support for fighting some of the world’s hardest to treat cancers. Our oncology work includes propelling the next generation of targeted small molecules, innovative immunotherapies like T-cell engagers to help a patient’s immune system target cancer cells, and new ways to use monoclonal antibodies to target specific biomarkers.

$name
$name

Oncology

Shining a Light on Multiple Myeloma: Insights from an Expert

Read More
Arrow
❮1 / 5❯
$name
$name

Oncology

United by Unique: Putting People at the Heart of Cancer Care

Read More
Arrow
❮2 / 5❯
$name
$name

Oncology

Advancement in Combination Biomarker-Driven Therapy for Adult Patients with Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer (mCRC)

Read More
Arrow
❮3 / 5❯
$name
$name

Oncology

A Fight for Hope: Inspiring Others Through Childhood B-ALL

Read More
Arrow
❮4 / 5❯
$name
$name

Oncology

A Journey of Courage: Empowering Others with Gastric Cancer

Read More
Arrow
❮5 / 5❯

Oncology Disease Areas

 

Blood Cancer

Someone in the U.S. is diagnosed with a blood cancer every ~3 minutes, accounting for an estimated 10% of new cancer diagnoses each year.1
Lung Cancer

With more than 2 million people diagnosed globally each year, lung cancer is the most common cancer in men and the second most common cancer in women.2
Gastrointestinal (GI) Cancers

Globally, GI cancers, which include colorectal and gastric cancers, account for one in four cancer cases and one in three cancer deaths.3
Prostate Cancer

In 2024, it is estimated that more than 299,000 men will be diagnosed with prostate cancer in the U.S.4
Other Solid Tumors

While cancer treatment has seen great progress in the last 30 years, there is still much to discover for the treatment of solid tumors.5
MORE STORIES

Conversations with the Community

 

Pipeline

Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.

LEARN MORE  

References

  1. Facts and Statistics. Leukemia and Lymphoma Society. https://www.lls.org/facts-and-statistics/facts-and-statistics-overview. Accessed September 16, 2024.
  2. Lung Cancer Statistics. World Cancer Research Fund International. https://www.wcrf.org/cancer-trends/lung-cancer-statistics/. Accessed September 6, 2022.  
  3. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. doi:10.3322/caac.21834.
  4. Cancer Facts & Figures 2023. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cancer-facts-and-figures.pdf. Accessed April 7, 2023.
  5. Gatzka MV. Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies. Cancers (Basel). 2018 24;10(6):155.